XClose

UCL Great Ormond Street Institute of Child Health

Home

Great Ormond Street Institute of Child Health

Menu

Dr Harry Leitch

Dr Harry Leitch is an Associate Professor and Honorary Consultant in Clinical Genetics and Genomic Medicine, based in the Genetics & Genomic Medicine Department at UCL Great Ormond Street Institute of Child Health and the North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Foundation Trust.

The Leitch group studies the germline cycle in vivo in mammalian embryos, and also in vitro using primary culture systems and pluripotent stem cell models – with the aim of improving our understanding of human development. We are particularly interested in how pluripotency is regulated during the germline cycle and how germ cell development is coordinated with the major germline epigenetic reprogramming events.

We also study how defects in early germline development can lead to severe forms of human infertility or, conversely, the development of germ cell tumours. In particular we are using human pluripotent stem cells to functionally validate findings from genomic investigations undertaken in infertile patients and to establish in vitro disease models of germline dysfunction.

We aim to expand this approach to study a broad range of early developmental disorders in children, with the hope that a better understanding of the underlying biology might lead to better treatment options. This is in keeping with Dr Leitch’s clinical work in the Department of Clinical Genetics at Great Ormond Street Hospital, where he specialises in paediatric rare disease genetics.  


Key Publications

2024

Sepulveda-Rincon LP, Wang YF, Whilding C, Ojarikre OA, Turner JMA, Leitch HG. Interrogating the potential of primordial germ cells by injection into early mouse embryos. Developmental Cell 59(6):695-704. DOI: 10.1016/j.devcel.2024.01.022

2024

Shah P, Hill R, Dion C, Clark S, Willems J, Abakir A, Arends M, Reik W, Leitch HG, Garaycoechea JI, Crossan G Primordial germ cell DNA demethylation and development require DNA translesion synthesis. Nature Communications 15, 3734. DOI: 10.1038/s41467-024-47219-2

2022

Santen GWE, Leitch HG, Cobben J. Gene-Disease Relationship Evidence: A clinical perspective focusing on ultra-rare diseases. Human Mutation 43:1082-1088. DOI: 10.1002/humu.24367

2021

Posfai E, Lanner F, Mulas C, Leitch HG. All models are wrong, but some are useful: establishing standards for stem cell-based embryo models. Stem Cell Reports 16(5):1117-1141. DOI: 10.1016/j.stemcr.2021.03.019

2021

Hamazaki N, Kyogoku H, Araki H, Miura F, Horikawa C, Hamada N, Shimamoto S, Hikabe O, Nakashima K, Kitajima T, Ito T, Leitch HG, Hayashi K. Reconstitution of the oocyte transcriptional network with transcription factors. Nature 286, 493-6. DOI: 10.1038/s41586-020-3027-9

2018

Zhang M*, LeitchHG*#, Tang WWC, FestucciaN, Hall-PonseleE, Nichols J, Surani MA, Smith A, Chambers I#. Esrrb complementation rescues development of Nanog-null germ cells. Cell Reports 9;22(2), 332-9. DOI: 10.1016/j.celrep.2017.12.060

2018

Hill PWS, Leitch HG*, Sun Z*, Requena-Torres C*, Amouroux R*, TruferoM, Borkowska M, Terragni J, Vaisvila R, Linnett S, Dharmalingham G, Haberle V,  Lenhard B, Zheng Y, Pradhan S, Hajkova P. Epigenetic reprogramming enables the primordial germ cell-to-gonocyte transition in mouse. Nature 555(7696), 392–396. DOI: 10.1038/nature25964